Here's what I said to Scott over there. The keyword is

Quote:

The keyword is 'possible'. Did Leo use the previous $45M shelf registration? Nope. Some said Leo will spend the first $30M Aspire deal down to the last dollar. Did he? Nope, $14M was left.

If Leo just obtained $75M via dilution, then I would agree that no deal is imminent. But that's not the case. Going into negotiation with $75M financing option is better than with $14M. Besides, having more money allows IPIX to acquire assets like Brilacidin if opportunity presents itself.

It's smart to have financial flexibility in business.